Germline single nucleotide polymorphisms in ERBB3 and BARD1 genes result in a worse relapse free survival response for HER2-positive breast cancer patients treated with adjuvant based docetaxel, carboplatin and trastuzumab (TCH)
about
Germline single nucleotide polymorphisms in ERBB3 and BARD1 genes result in a worse relapse free survival response for HER2-positive breast cancer patients treated with adjuvant based docetaxel, carboplatin and trastuzumab (TCH)
description
article publié dans la revue scientifique PLoS ONE
@fr
im Januar 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in PLoS ONE
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Germline single nucleotide pol ...... boplatin and trastuzumab (TCH)
@en
Germline single nucleotide pol ...... boplatin and trastuzumab (TCH)
@nl
type
label
Germline single nucleotide pol ...... boplatin and trastuzumab (TCH)
@en
Germline single nucleotide pol ...... boplatin and trastuzumab (TCH)
@nl
prefLabel
Germline single nucleotide pol ...... boplatin and trastuzumab (TCH)
@en
Germline single nucleotide pol ...... boplatin and trastuzumab (TCH)
@nl
P2093
P2860
P1433
P1476
Germline single nucleotide pol ...... boplatin and trastuzumab (TCH)
@en
P2093
Aoife Carr
Bryan Hennessy
Elaine Kay
Joanna Fay
John Crown
Malgorzata Milewska
Mattia Cremona
Simon Furney
Sinead Toomey
Stephen Madden
P2860
P304
P356
10.1371/JOURNAL.PONE.0200996
P407
P577
2018-08-02T00:00:00Z